Executive record
Jean-Pierre Sommadossi, Ph.D.
Public governance roles and source-backed Claims for this individual.
More
Alpha ID: alpha:person:jean-pierre-sommadossi-ph-d-avirVersion: public-0As of: 2026-09-30
Key Claims
Biography
Founder of Atea Pharmaceuticals, serving as President, CEO and Chairman since July 2012. Previously co-founded Idenix Pharmaceuticals and Pharmasset, Inc., and held CEO and Chairman roles at both companies.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Executive career
- 2026 to end not publishedExecutive title: President and Chief Executive Officer and Chairman of the Board of Directors · Organization not publishedAVIR 10-K executive officers
Claims
Conflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
AVIR 10-K executive officers
sec filing · Source published: Mar 5, 2026 · Retrieved: May 14, 2026
Supports 6 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 14, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 14, 2026
- Executive company: Executive at Atea Pharmaceuticals, Inc. · Claim reviewed: May 14, 2026
- Executive title: Executive title: President and Chief Executive Officer and Chairman of the Board of Directors · Claim reviewed: May 14, 2026
- Other Company Role: Jean-Pierre Sommadossi, Ph.D. is also linked to Panchrest, Inc. as Chairman of the board of directors. · Claim reviewed: May 14, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 14, 2026
AVIR executive roster source
sec filing · Source published: Date unavailable · Retrieved: May 3, 2026
Supports 5 claims
- AI expertise: AI expertise reported in filings · Claim reviewed: May 3, 2026
- AI governance relevance: AI governance relevance reported from role and filings · Claim reviewed: May 3, 2026
- Executive company: Executive at Atea Pharmaceuticals, Inc. · Claim reviewed: May 14, 2026
- Executive function: Enterprise Leadership (CEO) · Claim reviewed: May 3, 2026
- Executive title: Executive title: President and Chief Executive Officer and Chairman of the Board of Directors · Claim reviewed: May 14, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-30
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope

